OBJECTIVE: The current study aimed to analyze predictive factors of sentinel lymph node mapping failure in apparently early stages of endometrial cancer using intracervical indocyanine green injection. METHODS: A single-center prospective study was conducted between June 2019 and August 2023 at the Department of Gynecology and Obstetrics, University Hospital Brno, Czech Republic. All patients with apparently early stage (I or II according to FIGO [International Federation of Gynecology & Obstetrics] 2009) endometrial cancer, who were indicated for sentinel node biopsy were consecutively included. The injection of 4-6 mL of indocyanine green was applied superficially and deeply into cervical tissue at the 3- and 9-o'clock positions. Patients' clinical data, surgical characteristics, and histopathological information were recorded. Univariable and multivariable regression analyses were applied. RESULTS: A total of 225 patients were eligible during the study period. Considering bilateral and unilateral failed mapping together, the only statistically significant factors for risk of failure in univariable analysis were body mass index (BMI; P = 0.036), FIGO 2009 stage (P = 0.019), and the presence of a myoma (P = 0.017). Nevertheless, when the multivariable logistic regression analysis was applied, all factors became statistically insignificant except for myoma (P = 0.031). Regarding only bilateral mapping failure, in univariable analysis, BMI (P = 0.021) and FIGO 2009 stage (P = 0.046) were significant predictors of failure. Interestingly, multivariable logistic regression analysis revealed that in addition to BMI (P = 0.007), age (P = 0.004) was also an independent predictor of bilateral failure. CONCLUSIONS: Higher BMI and age were statistically significant independent factors for bilateral sentinel node mapping failure in early-stage endometrial cancer.

Department of Gynecology and Obstetrics University Hospital Brno Brno Czech Republic

Department of Pathology University Hospital Brno Brno Czech Republic

Faculty of Medicine Institute of Biostatistics and Analyses Masaryk University Brno Czech Republic

Faculty of Medicine Masaryk University Brno Czech Republic

Zobrazit více v PubMed

Concin N, Matias‐Guiu X, Vergote I, et al. ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma. Int J Gynecol Cancer. 2021;31(1):12‐39. doi:10.1136/ijgc-2020-002230

Concin N, Planchamp F, Abu‐Rustum NR, et al. European Society of Gynaecological Oncology quality indicators for the surgical treatment of endometrial carcinoma. Int J Gynecol Cancer. 2021;31(12):1508‐1529.

Accorsi GS, Paiva LL, Schmidt R, Vieira M, Reis R, Andrade C. Sentinel lymph node mapping vs systematic lymphadenectomy for endometrial cancer: surgical morbidity and lymphatic complications. J Minim Invasive Gynecol. 2020;27(4):938‐945.

Backes FJ, Cohen D, Salani R, et al. Prospective clinical trial of robotic sentinel lymph node assessment with isosulfane blue (ISB) and indocyanine green (ICG) in endometrial cancer and the impact of ultrastaging (NCT01818739). Gynecol Oncol. 2019;153(3):496‐499.

Buda A, Di Martino G, Restaino S, et al. The impact on survival of two different staging strategies in apparent early stage endometrial cancer comparing sentinel lymph nodes mapping algorithm and selective lymphadenectomy: an Italian retrospective analysis of two reference centers. Gynecol Oncol. 2017;147(3):528‐534.

Frumovitz M, Plante M, Lee PS, et al. Near‐infrared fluorescence for detection of sentinel lymph nodes in women with cervical and uterine cancers (FILM): a randomised, phase 3, multicentre, non‐inferiority trial. Lancet Oncol. 2018;19(10):1394‐1403.

Papadia A, Zapardiel I, Bussi B, et al. Sentinel lymph node mapping in patients with stage I endometrial carcinoma: a focus on bilateral mapping identification by comparing radiotracer Tc99m with blue dye versus indocyanine green fluorescent dye. J Cancer Res Clin Oncol. 2017;143(3):475‐480. doi:10.1007/s00432-016-2297-y

Eriksson AG, Beavis A, Soslow RA, et al. A comparison of the detection of sentinel lymph nodes using Indocyanine green and near‐infrared fluorescence imaging versus blue dye during robotic surgery in uterine cancer. Int J Gynecol Cancer. 2017;27(4):743‐747. doi:10.1097/IGC.0000000000000959

Raffone A, Fanfani F, Raimondo D, et al. Predictive factors of sentinel lymph node failed mapping in endometrial carcinoma patients: a systematic review and meta‐analysis. Int J Gynecol Cancer. 2023;33(6):853‐859. doi:10.1136/ijgc-2022-004014

Dundr P, Cibula D, Doležel M, et al. Molecular testing in endometrial carcinoma (joint recommendation of Czech Oncological Society, Oncogynecological Section of the Czech Gynecological and Obstetrical Society, Society of Radiation Oncology, Biology and Physics, and the Society of Czech Pathologists). Cesk Patol. 2021;57(3):181‐187.

Tortorella L, Casarin J, Multinu F, et al. Sentinel lymph node biopsy with cervical injection of indocyanine green in apparent early‐stage endometrial cancer: predictors of unsuccessful mapping. Gynecol Oncol. 2019;155(1):34‐38.

Ianieri MM, Puppo A, Novelli A, et al. Sentinel lymph node biopsy in the treatment of endometrial cancer: why we fail? Results of a prospective multicenter study on the factors associated with failure of node mapping with Indocyanine green. Gynecol Obstet Investig. 2019;84(4):383‐389.

Heppell C, Roose T, Richardson G. A model for interstitial drainage through a sliding lymphatic valve. Bull Math Biol. 2015;77(6):1101‐1131.

Taşkın S, Sarı ME, Altın D, et al. Risk factors for failure of sentinel lymph node mapping using indocyanine green/near‐infrared fluorescent imaging in endometrial cancer. Arch Gynecol Obstet. 2019;299(6):1667‐1672.

Sozzi G, Fanfani F, Berretta R, et al. Laparoscopic sentinel node mapping with intracervical indocyanine green injection for endometrial cancer: the SENTIFAIL study – a multicentric analysis of predictors of failed mapping. Int J Gynecol Cancer. 2020;30(11):1713‐1718. doi:10.1136/ijgc-2020-001724

Body N, Grégoire J, Renaud MC, Sebastianelli A, Grondin K, Plante M. Tips and tricks to improve sentinel lymph node mapping with Indocyanin green in endometrial cancer. Gynecol Oncol. 2018;150(2):267‐273.

Angeles MA, Migliorelli F, Ramírez LFL, et al. Predictive factors of preoperative sentinel lymph node detection in intermediate and high‐risk endometrial cancer. Q J Nucl Med Mol Imaging. 2023;67(1):37‐45. doi:10.23736/S1824-4785.20.03246-X